HSANZ / Leukemia Foundation PhD scholarships


Enrolment status New students
Student type Domestic students
Level of study Higher Degree by Research
Study area Medicine, Science and Mathematics
HDR funding type Living stipend scholarship
Scholarship value Provide total funding of no more than $130,000 comprising a stipend of $42,000 per annum including a consumable budget of up to $3,000 per annum and final payment of $4,000 on receipt of final report
Scholarship duration Until completion of the PhD for no more than three years of full-time study
Number awarded 3
Opening date 20 May 2021
Closing date 11 July 2021


The Haematology Society of Australia and New Zealand (HSANZ) and the Leukaemia Foundation are pleased to confirm their partnership and commitment to awarding doctoral scholarships to Australian applicants demonstrating outstanding merit in blood cancer or blood cancer related disorders.

Leukaemia Foundation 2022 PhD Research Priorities

This year, the Leukaemia Foundation and HSANZ will award up to three (3) PhD scholarships to successful applicants whose work aligns with at least one of the Leukaemia Foundation’s following research priorities:

  • Understanding the biology of blood cancers
  • Precision medicine - investing in new therapies that are tailor-made to treat each patient’s cancer
  • New diagnostics
  • Novel therapies
  • Innovative clinical trials and/or incorporation of real-world data
  • Prevention research including investigating blood cancer risk factors


To be eligible, you must meet the entry requirements for a higher degree by research

Please view the scholarship eligibility requirements on the HSANZ website.

Before you get started

If this scholarship has rules, download and read them.

How to apply

Please follow the application guidelines and process on the HSANZ website.

Applications close Sunday, 11 July at 11:59 pm


Haematology Society of Australia and New Zealand

Terms and conditions

Read the policy on UQ Research Scholarships.

For the other scholarship terms and conditions, please visit the HSANZ website.